Avanos Medical AVNS Accounts Receivable, Credit Loss Expense (Reversal)
Accounts Receivable, Credit Loss Expense (Reversal) at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's accounts receivable, credit loss expense (reversal).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's accounts receivable, credit loss expense (reversal)?
- Avanos Medical (AVNS) reported accounts receivable, credit loss expense (reversal) of -$400K in Q1 2026.
- How has Avanos Medical's accounts receivable, credit loss expense (reversal) changed year-over-year?
- Avanos Medical's accounts receivable, credit loss expense (reversal) decreased by 500.0% year-over-year, from $100K to -$400K.
- What is the long-term trend for Avanos Medical's accounts receivable, credit loss expense (reversal)?
- Over 3 years (2022 to 2025), Avanos Medical's accounts receivable, credit loss expense (reversal) has grown at a -32.5% compound annual growth rate (CAGR), from $2.6M to $800K.